Global Alpha-1 Antitrypsin Drugs Market 2016-2020

アルファ1-アンチトリプシン薬の世界市場2016-2020

◆タイトル:Global Alpha-1 Antitrypsin Drugs Market 2016-2020
◆商品コード:IRTNTR8456
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年4月27日
◆ページ数:58
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、アルファ1-アンチトリプシン薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アルファ1-アンチトリプシン薬の世界市場規模及び予測、投与経路(ROA)別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。

About Alpha-1 antitrypsin Drugs
Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as elastase, which break down proteins during inflammation induced by some injury. The decline in alpha-1 antitrypsin levels in the blood results in a rare genetic condition known as alpha-1 antitrypsin deficiency (AATD), which leads to the development of respiratory and liver diseases, and severe skin infections. The disease is passed on from parents to an offspring through mutated genes. Augmentation therapy using drugs derived from human plasma helps in maintaining levels of alpha-1 antitrypsin in the blood, helping in remission of the condition.

Technavio’s analysts forecast the global alpha-1 antitrypsin drugs market to grow at a CAGR of 35.42% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global alpha-1 antitrypsin drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded drugs and off-label drugs used for the symptomatic treatment of diseases occurring due to alpha-1 antitrypsin deficiency and other disorders.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Alpha-1 Antitrypsin Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Baxter International
• CSL Behring
• Grifols
• Kamada

[Other prominent vendors]
• Abeona Therapeutics
• Alnylam Pharmaceuticals
• Applied Genetic Technologies
• Arrowhead Research
• Baxalta
• Biogen
• Chiesi
• Curaxys
• Laboratoire français du Fractionnement et des Biotechnologies
• ProBioGen
• ProMetic Life Sciences

[Market driver]
• Improved diagnosis of alpha-1 antitrypsin deficiency (AATD)
• For a full, detailed list, view our report

[Market challenge]
• Limited plasma fractionation capacity
• For a full, detailed list, view our report

[Market trend]
• Increasing awareness about therapy
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Overview: Alpha-1 antitrypsin deficiency
• Pathophysiology
• Symptoms
• Diagnosis
• Management

PART 06: Overview: Alpha-1 antitrypsin drugs
• Components of blood plasma
• Regulation of plasma therapeutics
• Regulatory authorities
• Reimbursement

PART 07: Pipeline analysis
• D1-AAT
• B1-AAT
• C1-AAT
• rAAV1-CB-hAAT
• G1-AAT
• L1-AAT
• ARC-AAT
• AAT
• PTB-101 SDF Alpha
• ALN-AAT

PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 09: Market segmentation by route of administration
• Parenteral
• Inhalation

PART 10: Geographical segmentation
• Global alpha-1 antitrypsin drugs market by geography 2015-2020
• Alpha-1 antitrypsin drugs market in Americas
• Alpha-1 antitrypsin drugs market in EMEA
• Alpha-1 antitrypsin drugs market in APAC

PART 11: Market drivers
• Improved diagnosis of AATD
• Improving economic conditions
• Novel product opportunities
• High unmet needs

PART 12: Impact of drivers

PART 13: Market challenges
• Stringent regulations
• Limited plasma fractionation capacity
• Shortage of alpha-1 antitrypsin supply
• High cost of drugs

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Strategic alliances and M&A
• Patient assistance programs
• Increasing awareness about therapy

PART 16: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Baxter International
• CSL Behring
• Grifols
• Kamada
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Common symptoms of AATD
Exhibit 03: Blood plasma composition
Exhibit 04: Plasma proteins composition by percentage share
Exhibit 05: Process of derivation of alpha-1 antitrypsin from plasma
Exhibit 06: Regulatory policies of plasma proteins therapeutics
Exhibit 07: Global alpha-1 antitrypsin drugs market: Products in pipeline
Exhibit 08: Global alpha-1 antitrypsin drugs market 2015-2020 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global alpha-1 antitrypsin drugs market by geography 2015
Exhibit 11: Global alpha-1 antitrypsin drugs market by geography 2015-2020 ($ millions)
Exhibit 12: Alpha-1 antitrypsin drugs market in Americas 2015-2020 ($ millions)
Exhibit 13: Alpha-1 antitrypsin drugs market in EMEA 2015-2020 ($ millions)
Exhibit 14: Alpha-1 antitrypsin drugs market in APAC 2015-2020 ($ millions)
Exhibit 15: Global alpha-1 antitrypsin drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Global alpha-1 antitrypsin drugs market share analysis 2015
Exhibit 19: Baxter International: Business segmentation by revenue 2014
Exhibit 20: Baxter International: YoY growth rate and revenue of BioScience segment 2012-2014 ($ billions)
Exhibit 21: Baxter International: YoY growth rate and revenue of Glassia in the US, Canada, Australia and New Zealand 2012-2014 ($ millions)
Exhibit 22: Baxter International: Key takeaways
Exhibit 23: CSL Behring: Sales by area of therapy 2014
Exhibit 24: CSL Behring: Key takeaways
Exhibit 25: Grifols: YoY growth rate and revenue of bioscience segment 2012-2014 ($ billions)
Exhibit 26: Grifols: Key takeaways
Exhibit 27: Kamada: Business segmentation by revenue 2014
Exhibit 28: Kamada: YoY growth rate and revenue of Glassia (excluding US, Canada, Australia, and New Zealand) 2012-2014 ($ millions)
Exhibit 29: Kamada: Key takeaways



【掲載企業】

Baxter International, CSL Behring, Grifols, Kamada, Abeona Therapeutics, Alnylam Pharmaceuticals, Applied Genetic Technologies, Arrowhead Research, Baxalta, Biogen, Chiesi, Curaxys, Laboratoire français du Fractionnement et des Biotechnologies, ProBioGen, ProMetic Life Sciences.


【資料のキーワード】

アルファ1-アンチトリプシン薬、α1アンチトリプシン欠損症、α1アンチトリプシン、プロテアーゼ阻害薬、治療薬、パイプライン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[アルファ1-アンチトリプシン薬の世界市場2016-2020] (Global Alpha-1 Antitrypsin Drugs Market 2016-2020 / IRTNTR8456)販売に関する免責事項
[アルファ1-アンチトリプシン薬の世界市場2016-2020] (Global Alpha-1 Antitrypsin Drugs Market 2016-2020 / IRTNTR8456)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆